Key facts
- This page summarizes Sharon E. Underberg's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Mar 2026, 17:01.
Sharon E. Underberg - 03 Mar 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- EVP, GC & Corporate Secretary
- Issuer ticker
- IDXX
- Reported as of
- 03 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2026, 17:01:34 UTC
- Prior SEC filing
- 17 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sharon E. Underberg filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 05 Mar 2026.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001630353
Primary reporting owner
Underberg Sharon E.
- Relationship
- EVP, GC & Corporate Secretary
- Address
- ONE IDEXX DRIVE, WESTBROOK
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
- Signature date
- 05 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +197
- Change %
- +2.8%
- Price
- $505.53*
- Shares after
- 7,138
- Date
- 03 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Incentive Stock Option (right-to-buy)
Options Exercise
- Transaction value
- Shares
- -197
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 03 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 197
- Exercise price
- $505.53
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Grant of option to buy shares of Issuer common stock that vested on February 14, 2026.
Footnote F2
Not applicable.